Tubulin Redirects Toxic Proteins in Neurodegenerative Diseases

Researchers at Baylor College of Medicine have discovered a novel strategy to combat Alzheimer's disease and Parkinson's disease by leveraging tubulin, the building block of microtubules. These diseases are characterized by the toxic accumulation of Tau and alpha synuclein protein clumps in the brain. The study, published in Nature Communications, reveals that tubulin can prevent these proteins from forming harmful aggregates and instead guide them towards their normal, healthy functions of maintaining cell structure and supporting communication. This finding shifts tubulin's role from a passive casualty to an active protector against toxic protein aggregation. The team, including Lathan Lucas, Allan Chris M. Ferreon, and Josephine C. Ferreon, suggests that boosting tubulin levels could be a selective therapeutic strategy, preserving the healthy roles of Tau and alpha synuclein while curbing toxic aggregation. The research was supported by grants from the United States===National Institute of Neurological Disorders and Stroke, the United States===National Institute of General Medical Sciences, and the Robert A. Welch Foundation.